PI Industries Limited has incorporated PI Foundation, a wholly owned subsidiary registered as a not-for-profit organisation under Section 8 of the Companies Act, 2013. The incorporation was completed on October 19, 2026, with the registered office located in Udaipur, Rajasthan.

The move follows board approval granted on August 11, 2026. The Certificate of Incorporation was issued by the Ministry of Corporate Affairs on the same date the subsidiary was formally established. This structural change allows the company to channel its Corporate Social Responsibility (CSR) obligations through a dedicated legal entity.

Operational structure and purpose

PI Foundation is established specifically for carrying out CSR activities in accordance with Section 135 read with Schedule VII of the Companies Act, 2013. As a Section 8 company, it operates as a not-for-profit organisation. The listed entity and its subsidiaries hold 100% of the share capital, making it a wholly owned subsidiary.

The initial share capital subscription was made in cash, amounting to ₹1,00,000. The entity is registered with the Registrar of Companies, Jaipur, under the Ministry of Corporate Affairs.

Key incorporation details

Strategic context

The creation of PI Foundation centralises the company’s social responsibility initiatives under a single, dedicated legal framework. By incorporating this entity, PI Industries aligns its CSR execution with statutory requirements while maintaining full control over the subsidiary’s operations and funding. The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

PI Industries Limited has secured registration for Pioxaniliprole, India’s first indigenously discovered insecticide, under section 9(3) of the Insecticides Act, 1968. The approval, granted by the Ministry of Agriculture & Farmers Welfare, covers the Technical Intermediate Material (TIM) and Formulated Intermediate Material (FIM) categories.

The registration committee approved the molecule on September 10, 2026, with the decision published on September 21, 2026. The company disclosed the development pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Product Details

Pioxaniliprole, branded as 'Pioxazon', represents a decade of research by the company. It is currently approved for the domestic market only. The company plans to launch the product in India soon to address crop productivity challenges.

Strategic Significance

The approval underscores PI Industries' evolution into a global-scale innovator in Agri Sciences. As an indigenously developed molecule, Pioxaniliprole reduces dependency on imported active ingredients and supports the country's agricultural innovation journey.